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Abstract
The genus Cyphostemma (Planch.) Alston (Vitaceae) includes about 150 species distrib-
uted in eastern and southern Africa and Madagascar. Some species are used in traditional
medicine and their biological activities, including antiproliferative effects against cancer cell
lines, have been demonstrated. To date no investigations on Cyphostemma essential oils
have been carried out. Essential oils, which play important roles in plant defenses have
been demonstrated to be active in the treatment of several human diseases and to enhance
bioavability of other drugs. The aim of this paper was to identify the chemical composition of
the essential oil of the leaves of Cyphostemma juttae (Dinter & Gilg) Desc. and to verify
some biological activities on two triple negative breast cancer cell lines (MDA-MB-231, SUM
149), characterized by the over-expression of the transcription factor NF-κB. In the essential
oil, obtained by hydrodistillation and analysed by gas chromatography-mass spectrometry,
39 compounds were detected and with phytol (30%) dominating the chemical composition.
C. juttae essential oil reduced cell growth and showed a pro-oxidant activity in both cell
lines. Moreover, C. juttae essential oil caused a substantial decrease of NF-κB activation
and consequently a significant reduction of some NF-κB target genes. The present study
shows for the first time the cytotoxic properties of C. juttae essential oil and highlight its avail-
ability to interfere with NF-κB pathway, suggesting a potential therapeutic use in triple nega-
tive breast cancers (TNBCs) of this essential oil.
Introduction
The genus Cyphostemma (Planch.) Alston (Vitaceae) includes about 150 species distributed in
eastern and southern Africa and Madagascar [1]. Some species from this genus are used in tra-
ditional medicine, e.g. roots of C. junceum to treat snake bites [2]. Interestingly, Ochawang’i
et al. [3] described the use of C. serpens, alone or in association with other plants, in traditional
medicine for the care of breast cancer. Udegbunam et al. [4] used root extracts of C. vogeli to
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investigate its anti-inflammatory effect on sore throat, cough and pneumonia in mice. The
antiproliferative effects of water and methanolic extracts of four Cyphostemma spp. (C. flavi-
florums, C. lanigerum, C. natalitium, and one unidentified species) on HepG2 cell line have
been studied by Opoku et al. [5], but no chemical analyses of the matrices were performed.
Cao et al. [6] found that C. greveana showed antiproliferative activities against the A2780 ovar-
ian cancer cell line and identified one macrolide, lasiodiplodin, three sesquiterpenoids, and a
new diterpenoid. Although from a chemical point of view Cyphostemma spp. have been inves-
tigated by solvent extractions, to the best of our knowledge no studies have been carried out
on hydrodistillated essential oils and their possible biological activities.
The aim of this paper was to identify the chemical composition of the essential oil of the
leaves of Cyphostemma juttae Dinter & Gilg (Desc.) obtained by hydrodistillation (HD) and
analyzed by gas chromatography-mass spectrometry (GC-MS), and to verify some biological
activities on two triple negative breast cancer cell lines (MDA-MB-231, SUM 149). Triple neg-
ative breast cancers (TNBCs) are highly aggressive, do not respond to conventional hormonal
interventions due to the lack of the respective receptor targets, have chances of early recur-
rence, metastasize, tend to be more invasive in nature, develop drug resistance and they are
also characterized by the over-expression of the transcription factor NF-κB [7]. The relevance
of the NF-κB transcription factor in tumor biology is widely known, even in triple negative
breast cancer.
Material and methods
Plant species
Cyphostemma juttae (Dinter & Gilg) Desc. (Vitaceae) is a tree-like succulent plant up to 2
meters tall that forms a massive caudex with thick branches. Stems and branches are covered
in yellow and papery skin, peeling off with age. Leaves are deciduous, succulent, up to 20 cm
long and 6 cm wide, and are produced in Summer during the vegetative season. This species
grows in Namibia, it is adapted to very dry environments and it is also cultivated as ornamen-
tal in specialized collections.
Plant material
Leaves of Cyhostemma juttae were collected in July 2017 from plants cultivated at the Botanical
Garden of the University of Palermo. The plants were raised from seeds in 1984 and pot culti-
vated in the open with references code: Vitaceae N-146. The matrices were placed in paper
bags and kept at -30˚C for 24 hours before hydrodistillation. No specific permits were required
for the described location and for the collection of plant material because the plants are part of
the living collection of the Botanical Garden of the University of Palermo and the authors have
access to that. The plant species used in the present study is not endangered and the IUCN cat-
egory assessed is Least Concern [8]; the seeds were obtained and the plants raised before the
Convention on Biological Diversity (CBD) entered into force on 29 December 1993 and there-
fore are pre-CBD specimens.
Essential oil
Leaves (868 g) were hand-cut into small pieces (~ 2 cm) and hydrodistillated for 3 hours in a
Clevenger-type apparatus, using n-pentane as collection solvent. The oil was dried by anhy-
drous sodium sulphate and stored at -30˚C until chemical analysis and pharmacological tests.
The essential oil yield was 17.36 mg (0.002%). To prepare the stock solution for biological stud-
ies 2 mg of essential oil were dissolved in 1 ml of dimethyl sulfoxide (DMSO).
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Gas chromatography-mass spectrometry
Essential oil sample was analyzed by GC-MS on a Shimadzu GC-MS-QP2010 Ultra equipped
with an AOC-20i autoinjector (Shimadzu, Kyoto, Japan) and a ZB-5 fused silica column (5%
phenyl polysiloxane; 30 m long, inner diam 0.32 mm, film thickness 0.25 μm, Phenomenex).
One μl of diluted sample (5x10-3, in n-pentane) was injected at 280˚C in a split ratio of 1:1, and
the column flow (carrier gas: helium) was set at 3 mL min-1. The GC oven temperature was
held for 1 min at 60˚C, then increased by 10˚C min-1 to 300˚C and held for 5 min. The MS
interface worked at 300˚C, and the ion source at 200˚C. Mass spectra were taken at 70 eV (in
EI mode) from m/z 30 to 450. The GC-MS data were processed using the GCMSolution pack-
age, Version 4.11 (Shimadzu Corporation 1999–2013).
Identification of compounds
Compounds were identified by using the mass spectral libraries [9], FFNSC 2, W9N11, and
ESSENTIAL OILS (available in MassFinder 3) and the Kovats Retention Indices (KRI) of the
compounds based on n-alkane series. We only considered compounds which had a mass spec-
tral similarity more than 70% respected to those present in our digital libraries and which had
a calculated Kovats index ± 10 compared to available data bases [9,10] and Nist11.
Cell growth assays
Triple negative breast cancer cell lines (MDA-MB-231, SUM 149) were used. The human
breast cancer cell lines MDA-MB-231 (ATCC: HTB-26—Rockville, MD, USA) and SUM149
(SUM149PT—Asterand Bioscience Detroit, MI) were kindly provided by Dr. Elda Tagliabue
(Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine,
Fondazione Institute of Hospitalization and Scientific Care, National Cancer Institute, Milan,
Italy) and were authenticated using the short tandem repeat profiling method in their Institute.
The non-tumorigenic cell line 1-7HB2 (ECACC 10081201—Cancer Research Technology,
London, UK) was kindly provided by Prof. Giulio Ghersi (STEBICEF Department, University
of Palermo, Italy).
MDA-MB-231 cell line was cultured in RPMI-1640 and the SUM 149 cell line was cultured
in DMEM/F-12 supplemented with insulin (5 μg/ml). 1-7HB2 cell line was cultured in DMEM
low glucose supplemented with hydrocortisone (5 μg/ml) and insulin (10 μg/ml). All media
were supplemented with 10% heat-inactivated fetal calf serum, 2 mM L-glutamine, 100 U/ml
penicillin and 100 μg/ml streptomycin (all reagents were from EuroClone S.p.A., Milan, Italy;
GE Healthcare Life Sciences, Logan, UT, USA). The cells were cultured in a humidified atmo-
sphere at 37˚C in 5% CO2. After obtaining the cells, the first passage carried out was assigned
passage number 1. Cells with a narrow range of passage number (4 ± 6) were routinely tested
for Mycoplasma contamination were used for all experiments.
The cells were seeded at 2 × 104 cells/well onto 96-well plates and incubated overnight at 37˚C.
At time 0, the medium was replaced with fresh complete medium supplemented of essential oil
at the indicated concentrations. Following 72 h of treatment, 16 μl of a commercial solution
obtained from Promega Corporation (Madison, WI, USA) containing 3-(4,5-dimethylthiazol-
2-yl)-5-(3-carboxy methoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium (MTS) and phenazine
ethosulfate were added. The plates were incubated in a humidified atmosphere at 37˚C in 5%
CO2 for 2 h, and the bioreduction of MTS dye was evaluated by measuring the absorbance of
each well at 490 nm using a microplate absorbance reader (iMark Microplate Reader; Bio- Rad
Laboratories, Inc., Hercules, CA, USA). Cell growth inhibition was expressed as a percentage
(mean ± SE) of the absorbance of the control cells.
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Anti- and pro-oxidant activity
To evaluate antioxidant activity, DPPH assay was used. The antiradical efficiency of the sample
was evaluated by the DPPH stable radical method [11, 12]. 100 μl of sample, the essential oil of
C. juttae at different concentrations, was added to aliquots (3.9 mL) of a solution made up
with DPPH (4.8 mg) in MeOH (200 ml), and the mixture was incubated for 1 h at room tem-
perature in the dark. Then the absorbance was measured at 517 nm using a UV-VIS spectro-
photometer. The initial concentration of DPPH was approximately 60 μM. Lower absorbance
values of reaction mixture indicate higher free radical scavenging activity. The results were
plotted as the percentage of absorbance disappearance at 517 nm [(1-A/A0) × 100] against the
amount of sample divided by the initial concentration of DPPH. Each point was acquired in
triplicate. ED50 corresponds to micrograms of fraction able to consume half the amount of free
radical divided by micromoles of initial DPPH. The results were expressed as antiradical
capacity (ARC), which is the inverse of ED50.
Trolox (6-hydroxy-2,5,7,8-tetramethyl-chroman-2-carboxylic acid) curve was used as the
positive control. Pro-oxidant activity was examined by cell counting, adding N-acetyl-L-cyste-
ine (NAC), an antioxidant molecule, 1 h before essential oil. Data were expressed as
mean ± standard error (SE) of at least three different experiments performed in duplicate. All
the chemicals were supplied by Sigma Aldrich srl, Milan, Italy.
Extraction of cellular RNA and reverse transcription-quantitative PCR
(RT-qPCR)
Total RNA was extracted from cell lines using TRIzol reagent (Invitrogen Life Technologies).
For the evaluation of gene expression, RNA was reverse transcribed using a high capacity com-
plementary DNA (cDNA) reverse transcription kit (Applied Biosystems Life Technologies).
The resulting cDNAs were subjected to real-time RT-PCR using the TaqMan Gene Expression
Master Mix kit (Applied Biosystems Life Technologies) in triplicates. The PCR cycling condi-
tions were as follows: Denaturation at 50˚C for 2 min, annealing at 95˚C for 10 min, followed
by 40 cycles of 95˚C for 15 sec and extension at 60˚C for 60 min. The running of the samples
and data collection were performed on a StepOne AB Real Time PCR system (Applied Biosys-
tems Life Technologies). β-actin was used as an internal standard. The specific primers used
were as follows: Survivin Hs00153353, XIAP Hs00236913, Bcl-2 Hs00236329, ABCB1
Hs00184005 (Applied Biosystems Life Technologies).
Relative expression was calculated using the comparative Ct method [ΔCt = Ct(target gene)-
Ct(housekeeping gene)]. Where Ct was the fractional cycle number at which the fluorescence of
each sample passed the fixed threshold. Fluorescence was measured at 515–518 nm using Ste-
pOne AB Real Time PCR System software (Applied Biosystems Life Technologies). The ΔΔCt
method was used to determine gene expression levels. ΔΔCt was calculated using the formula:
ΔΔCt = ΔCt(each sample)-ΔCt(reference sample). Fold change was calculated using the 2
-ΔΔCt
equation.
Western blotting
Whole-cell lysates were obtained from breast cancer cells using RIPA buffer (Santa Cruz Bio-
technology Inc., Dallas, TX, USA) and 25 μg protein was subjected to 10% SDS-PAGE and
transferred to Hybond-P membranes (GE Healthcare Europe GmbH, Freiburg, Germany). Fil-
ters were incubated with primary antibodies raised against GAPDH (0411) (sc-47724 mouse
anti-human polyclonal antibody 1:10000), Bcl-2 (sc-509 mouse anti-human monoclonal anti-
body 1:200) from Santa Cruz Biotechnology Inc., Dallas, TX, USA, Inc, XIAP (#2042, rabbit
Antitumor mechanism of Cyphostemma juttae essential oil in TNBC cells
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anti-human antibody, 1:500) from Cell Signaling Technology, Danvers, MA, Survivin (NB500-
201, rabbit anti-human polyclonal antibody, 1:2000) from Novus Biologicals, Littleton, CO.
Immunoblots were quantified by densitometry and results were expressed as arbitrary units
(protein/GADPH).
NF-κB activation
The DNA-binding capacity of NF-κB (p65 subunit) was determined in the nuclear extracts of
MDA-MB-231 and SUM 149 cells using the TransAM NF-κB and Nuclear Extract kits (Active
Motif, Carlsbad, CA, USA) according to the manufacturer’s instructions. The cells were treated
with 46 μg/ml and 64 μg/ml, respectively, of the essential oil for 24 h. Briefly, the determination
of binding capacity was based on a 96-well plate, upon which an oligonucleotide containing
the NF-κB consensus binding site (5’-GGGACTTTCC-3’) was immobilized. Activated NF-κB
contained in the extracts is able to specifically bind to this nucleotide. NF-κB bound to the oli-
gonucleotide may subsequently be detected using an antibody directed against an epitope on
p65 (polyclonal rabbit anti-human; cat. no. 40096; 1:1000; Active Motif), accessible only when
NF-κB is bound to its target DNA.
Subsequently, the addition of a horseradish peroxidase-conjugated secondary antibody pro-
vided a sensitive colorimetric readout that may be quantified by densitometry (iMark Micro-
plate Reader; Bio-Rad Laboratories, Inc.). The specificity of the assay was confirmed by
simultaneous incubations in the presence of excess, non-immobilized consensus oligonucleo-
tides, as a competitor, or of a mutated consensus oligonucleotide. The results were expressed
as arbitrary units: one unit indicated the DNA binding capacity exerted by 2.5 μg whole cell
extract from Jurkat cells (positive control for NF-κB p65 activation; Active Motif) (stimulated
with 12-O-tetradecanoylphorbol-13-acetate and calcium ionophore) per microgram of protein
from the nuclear extracts.
Statistical analysis
Results of bioassays are given as means ± standard error (SE). Statistical analysis was carried
out according to Poma et al. [13] by analysis of variance (one-way ANOVA) followed by
Tukey’s test. Statistica ver. 12 (StatSoft Inc. 1984–2014) was used as software for the analyses.
Results
The yield in essential was 0.002%. The plants from which the leaves were collected completed
flowering and produced viable seeds. In the year 2018 the plants produced new leaves and the
growth was not affected by the previous year removal of leaves.
Chemical composition
In the essential oil of C. juttae, considering compounds with mass spectral similarities� 70%
in respect to our libraries, we detected 39 compounds (80% of the whole composition). Of
these, 3 were classified as unknowns while 36 belonged to 18 different class and functional
group of compounds.
Overall, the composition was dominated by Terpenenoid compounds with 64.9%, followed
by Aliphatic Acids (7%) and Aliphatic Alkanes (2.9%). The most abundant compounds
(> 4.0%) were phytol (29.6%; Fig 1), neophytadiene (6.6%) with its isomer III (4.6%), hexade-
canoic acid (5.5%), 3-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-2-propenal (5.5%) and isophytol
(4.6%), contributing together 56.4% of the total composition accounting to 80.3%.
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Nine compounds were detected in relative amounts between 1 and 4% (heptacosane, tetra-
decanoic acid, 1-(2,3,6-trimethylphenyl)-2-butanone, piperitenone, (E)-β-damascenone and
carvacrol), whereas 24 compounds were found in amounts < 1% (Table 1).
In vitro anticancer and pro-oxidant activity
We examined the cytotoxic activity of C. juttae essential oil on MDA-MB-231 and SUM 149
cells by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-
tetrazolium (MTS) assay. The essential oil of C. juttae reduced cell growth in a dose dependent
way, in particular the cell line more sensitive was MDA-MB-231 (Fig 2). The essential oil did
not show cytotoxic activity on the non-tumorigenic cell line 1-7HB2. The cell growth inhibi-
tion was: 0% at 30 μg/ml; 10 ± 2% at 50 μg/ml; 17.5 ± 1.5% at 70 μg/ml; and 23 ± 2% at 100 μg/
ml.
Since many natural compounds are provided with anti- or pro-oxidant activity, we ana-
lyzed if the antitumor activity of the C. juttae oil was due to pro-oxidant activity. The cells
were treated with the antioxidant N-acetyl-L-cysteine (NAC) at 2mM 1 h before exposure to
the essential oil at the corresponding IC50 values. In both cell lines the addition of NAC
reduced cytotoxic activity, in particular the reduction was more evident in MDA-MB-231 cell
line (Table 2).
In addition, the analysis carried out by DPPH (2,2-diphenyl-1-picrylhydrazyl) reduction
assay indicated that the essential oil does not possess antioxidant activity, since it was not iden-
tified the efficient dose (ED50) of the essential oil of C. juttae (Table 3). These results indicate
that the mechanism involves an at least partially pro-oxidant effect.
Inhibition of NF-κB activation
In order to investigate the molecular mechanism underlying the antitumor activity of the
essential oil, we analyzed the effects of the essential oil to NF-κB activation by TransAM assay.
MDA-MB-231 and SUM 149 cells were treated with the essential oil at the corresponding IC50
values for 24 h: in both cell lines we observed a strong reduction of NF-κB DNA-binding activ-
ity (Fig 3).
In view of this, the treatment with the essential oil also caused a substantial mRNA decrease
of some NF-κB target genes, in particular antiapoptotic factors such as Survivin, XIAP, Bcl-2
and the multidrug efflux transporter P-glycoprotein, encoding by ABCB1 gene (Fig 4).
Fig 1. Mass spectra and chemical structure of phytol found in the present study.
https://doi.org/10.1371/journal.pone.0214594.g001
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Table 1. Essential oil composition of C. juttae. Compounds belonging to the same chemical class and functional group are arranged according to Kovats Retention Indi-
ces (KRI) of the ZB-5 column.
KRI Compound Relative amount (%) MS Similarity (%)
Aliphatic Alcohols
898 2-Heptanol 0.2 96
1096 1-Octanol 0.1 93
Aliphatic Aldehydes
858 (E)-2-Hexenal 0.7 96
1104 Nonanal 0.6 97
Aliphatic Alkanes
2300 Tricosane 0.1 90
2500 Pentacosane 0.3 85
2700 Heptacosane 2.5 90
Aliphatic Esters
1190 Butyl hexanoate 0.1 91
1386 Hexyl hexanoate 0.4 92
2105 Methyl linolenate 0.5 95
Aliphatic Acids
1758 Tetradecanoic acid 1.5 94
1961 Hexadecanoic acid 5.5 92
Aromatic Esters
1780 Benzyl benzoate 0.1 94
Aromatic Hydrocarbons
1029 1,4-Diethylbenzene 0.1 90
1161 1,2,4,5-Tetramethylbenzene 0.1 88
Aromatic Ketones
1593 1-(2,3,6-Trimethylphenyl)-2-butanone 1.1 82
Diterpene Alcohols
1950 Isophytol 4.6 96
2118 Phytol 29.6 97
Monoterpene Alcohols
1100 Linalool 0.1 95
1303 Carvacrol 4.0 80
Monoterpene Ethers
1077 (Z)-Linalool oxide furanoid 0.1 94
1093 (E)-Linalool oxide furanoid 0.1 92
Monoterpene Hydrocarbons
981 p-Cymene 0.01 80
1034 Limonene 0.1 96
Monoterpene Ketones
1249 Pulegone 0.7 96
1353 Piperitenone 1.7 96
Irregular terpene Aldehydes
1410 3-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-2-propenal 5.5 81
Irregular terpene Ketones
1394 (E)-β-Damascenone 1.6 94
1456 Geranylacetone 0.3 89
Sesquiterpene Alcohols
1600 Fokienol 0.3 90
(Continued)
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Table 1. (Continued)
KRI Compound Relative amount (%) MS Similarity (%)
1673 α-Cadinol 0.6 89
Sesquiterpene Ethers
1605 Caryophyllene oxide 0.7 94
Sesquiterpene Hydrocarbons
1693 Cadalene 0.2 87
1840 Neophytadiene 6.6 94
1865 Neophytadiene, Isomer II 2.5 94
1883 Neophytadiene, Isomer III 4.6 96
Unknowns
1206 m/z: 131(100), 159(72), 57(61), 91(58), 41(56), 55(41) 0.4 71
1310 m/z: 105(100), 120(79), 91(65), 119(58), 92(32), 77(27) 1.1 79
2142 m/z: 79(100), 253(62), 67(61), 93(50), 80(44), 41(42) 1.1 79
Total 80.3
https://doi.org/10.1371/journal.pone.0214594.t001
Fig 2. Cytotoxic activity of C. juttae essential oil on cancer cell lines. Cell viability was assessed by MTS. Data are expressed as
mean ± standard error (SE) of at least three different experiments performed in triplicate. Different letters represent significant differences in
cytotoxic activity among the concentrations of each cell line (Tukey test, p< 0.05).
https://doi.org/10.1371/journal.pone.0214594.g002
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In both cell lines we found a reduction also at protein level of anti-apoptotic factors (Survi-
vin, XIAP and Bcl-2) under essential oil treatment (Fig 5).
The strong reduction of mRNA level of P-gp under treatment with essential oil in our cell
lines is significant but the analysis of the drug resistance implies further experimental evalua-
tions that are in progress. However, it is known that the expression of P-gp is also regulated by
post-translational events, such as post-transcriptional glycosylation and membrane localiza-
tion of P-gp [14].
Discussion
Essential oils and their chemical constituents have potential roles and uses to prevent and treat
human disease. The role of these natural products has been discussed with regard to the pre-
vention and treatment of cancer, cardiovascular diseases, and as antibacterial, antiviral, and
antioxidant agents, among others [15].
Since C. juttae is a plant species adapted to dry environments with high temperature, high
light intensity, and low nutrient and water resources the risk of damage by abiotic and biotic
factors can be easy to occur. However, by the biosynthesis of a wide range of secondary metab-
olites this species, growing in nature in prohibitive habitats, can develop defensive strategies
against several biotic and abiotic factors.
Our chemical composition indicates that C. juttae essential oil constituents potentially may
play several biological roles. Among others, terpenoids contributing to more than 60% of C.
juttae composition are the largest group of plant chemicals which have multiple ecological
roles, such as: (1) defense against generalist and specialist herbivores, (2) defense against fungi
and bacteria, (3) attraction of pollinators and seed dispersers, (4) allelopathic agents that
inhibit seed germination, and (5) protection against abiotic factors (e.g. with reactive
Table 2. Results of cell counting analysis in the two cell lines following treatment with antioxidant N-acetyl-L-cys-
teine (NAC) at 2mM before exposure to the essential oil at the corresponding IC50. Data are expressed as
mean ± standard error (SE).
Cell lines and treatments Cell viability (%)
MDA-MB-231
+ NAC 2 mMa,�� 73.6 ± 2.6
+ essential oil of C. juttae 46 μg/mLb,�� 45.0 ± 4.0
+ NAC 2 mM + essential oil of C. juttaea,�� 72.6 ± 0.4
SUM 149
+ NAC 2 mMa 98.6 ± 1.4
+ essential oil of C. juttae 64 μg/mLb,�� 52.0 ± 6.0
+ NAC 2 mM + essential oil of C. juttaeab,� 74.4 ± 4.4
Different letters (a and b) in the column of the cell lines and treatments represent significant differences among the
treatments of each cell line
differences when treatments are compared to the control
�p < 0.05
��p < 0.01.
https://doi.org/10.1371/journal.pone.0214594.t002
Table 3. Results of antioxidant activity performed with DPPH method (DPPH free radical scavenging activity).
Compound ED50 ACR (1/ED50)
Trolox 68 μg/ml 0.015
Essential oil >100μg/ml -
https://doi.org/10.1371/journal.pone.0214594.t003
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troposphere gases) [16, 17]. According to Gershenzon and Dudareva [18] considering the
large number of terpenoids produced in nature, very little is known about their mode of action
at the molecular level although their highly lipophilic nature suggests that they act on the cell
membranes and that their toxicity is caused by loss of chemiosmotic control.
Many plant-derived active principles have gained attention as efficient anticancer agents
against TNBCs, with fewer adverse side effects. In this work for the first time we described the
strongly inhibitory effect of C. juttae essential oil on NF-κB activation in two TNBC cell lines
characterized by a strong expression of the transcriptional factor. Consequently, the inhibition
of transcriptional activity due to essential oil leads to a significant decrease of some transcrip-
tional target genes such as Survivin, XIAP, Bcl-2 and P-glycoprotein [19, 20, 21, 22].
Moreover, in the same cancer models, the essential oil showed antitumor capacities in the
terms of cytotoxic and pro-oxidant activities and partially pro-apoptotic effects proven by pre-
liminary cytofluorimetric analysis by propidium iodide where only a modest block in
Fig 3. NF-κB (p65 subunit) DNA binding capacity in nuclear extracts of MDA-MB-231 cells (A) and of SUM 149 cells (B). The cells were treated for 24 h
with C. juttae essential oil (EO) (46 and 64 μg/ml, respectively). Results (mean ± standard error of two experiments carried out in duplicate) are expressed as
arbitrary units/μg protein of cells nuclear extracts. Statistical differences are �p< 0.05 vs. control.
https://doi.org/10.1371/journal.pone.0214594.g003
Fig 4. Genes mRNA expression levels by quantitative polymerase chain reaction in MDA-MB-231 cells (A) and SUM 149 cells (B). The cells were treated
for 24 h with C. juttae essential oil (EO) (46 and 64 μg/ml, respectively). Data are expressed as mean ± standard error (SE) of two different experiments.
Different letters (a, b, c and d) in the column of the cell lines and treatments represent significant differences (p< 0.05) among the treatments of each cell line;
�differences when treatments are compared to the control (p< 0.05).
https://doi.org/10.1371/journal.pone.0214594.g004
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preG0-G1 position dose-dependent is observed in all cell lines and also shown in other studies
[23]. It is very interesting to note that the essential oil exerts an inhibitory effect on the tran-
scription of the P-glycoprotein the ABCB1 multi-drug efflux pump (MDR). P-glycoprotein is
overexpressed in TNBCs and analysis of the MDR reversal activities of essential oil request fur-
ther analyses [24, 25, 26]. In sight of this plant-derived compounds in combination with classi-
cal chemotherapeutic agents could be more efficient in the treatment of TNBCs, possibly with
lesser side effects.
Our results on the chemical composition of the C. juttae essential oil shown that Phytol is
the main compound (29.6%). Based on these data, it could be hypothesized that the biological
activities of essential oil in our TNBC cells, are accountable mainly to phytol which in combi-
nation with other terpenoids can act with synergic effects. On the other hand, the antitumor
activity of this compound has been already described by Islam et al. [27] in different type of
cancer models, such as human gastric adenocarcinoma, lymphoid leukemia, hepatocellular
carcinoma and also in one triple negative breast cancer cell line. There are other evidences that
showed how the immunomodulatory and antitumor effects of the Phytol can be attributed pre-
cisely to the action on NF-κB [27].
Conclusions
Our studies have shown that essential oil of C. juttae exhibits the remarkable property to dis-
turb NF-κB molecular pathway and it could be useful to sensitize the TNBCs to the conven-
tional antitumor drugs.
Fig 5. Western blotting analysis in MDA-MB-231 cells and SUM 149 cells. The cells were treated for 24 h with C.
juttae essential oil (EO) (46 and 64 μg/ml, respectively). The data shown are the results of a representative experiment.
https://doi.org/10.1371/journal.pone.0214594.g005
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